论文信息 - Comparisons of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9I) versus Ezetimibe on Major Adverse Cardiovascular Events Amongst Patients with Dyslipidaemia: A Population-Based Study - 字舞流文

Comparisons of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9I) versus Ezetimibe on Major Adverse Cardiovascular Events Amongst Patients with Dyslipidaemia: A Population-Based Study

B. Leung | Lifang Li | Jiandong Zhou | Carlin Chang | A. K. Wai | G. Tse | O. Chou | C. Chung | Lei Lu | Quinncy Lee | Hugo Hok Him Pui | Tong Liu | G. Lip | Bernard Man Yung Cheung MB BChir | H. Pui